Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
NCT00268411
Interventional
Phase 3
Unknown status
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. It is not yet known whether giving both of these drugs on the same day is more effective than giving them on different days. PURPOSE: This randomized phase III trial is studying two different schedules of gemcitabine and oxaliplatin to compare how well they work in treating patients with metastatic pancreatic cancer.
Sep 30,2004
All
18 Years
N/A
18 Years
N/A
80